It has been reported that vascular ECs undergoing inflammatory changes in the tumor microenvironment secrete high levels of CCL2, which attracts neutrophils and activates them, suggesting that neutrophil activation takes place through the inflamed ECs as a new mechanism (Tsumita et al., 2022). The gene discussed is CCL2; the disease is neoplasm.